Irene Moreno, M.D., is a Medical Oncologist and a Principal Investigator of START Madrid-CIOCC.

Dr. Moreno earned her Medical Degree in 2011 at the University of Extremadura, Spain, having done her 3rd year of medicine in the University of Salamanca (2007/2008) and her 5th year in the University of Careggi in Florence, Italy (2009/2010); as part as two international student programs.

She also spent the Summer of 2008 doing an internship at Agia Sophia Hospital in Athens (Greece) in the area of pediatric oncology. After completing her medical degree she spent two months volunteering in rural zones as a general doctor, in Zamora co., Ecuador (February-March, 2012). In 2017, she completed her training as a Medical Oncologist at the Fundación Jiménez Díaz Universitary Hospital, in Madrid (Spain).

Irene also had the opportunity during her training to join the Lank Center for Genitourinary Cancer in “Dana Farber Cancer Institute”, Boston, USA (April-September 2016) as a clinical fellow, participating in some of his lines of investigation, especially in bladder cancer. After finishing her training she was offered to join the Drug Development Unit in The Royal Marsden Hospital, based in Sutton, London (August 2017-August 2018).

Afterward, she returned to Fundación Jiménez Díaz Hospital to work as a consultant in the genitourinary area, collaborating, once again, with several investigational projects. As of January 2019, Dr. Moreno has been working at START Madrid-CIOCC as a Clinical Investigator at the Early Drug Development Unit. She has been involved in more than 60 Phase I clinical trials; including First in Human trials, immunotherapy trials, targeted therapy trials, biomarker-driven trials, and trials in molecularly selected populations with special emphasis on sarcoma, genitourinary and head and neck tumors. She is currently working on her PhD, which started when she was a medical oncology trainee.

Dr. Moreno has authored and co-authored of several papers in peer-reviewed journals. Irene is also a member of the European Society of Medical Oncology and the Spanish Society of Medical Oncology.